FDA Cuts Prompt Biotech Players To Rethink Deal Strategies - Law360

Barbara Binzak Blumenfeld, shareholder and FDA & Biotechnology section chair, was quoted in a Law360 article entitled "FDA Cuts Prompt Biotech Players To Rethink Deal Strategies."